Haemonetics (HAE) is scheduled to report first-quarter fiscal 2025 results on Aug 8, before market open.Earnings Surprise HistoryHAE has a strong earnings surprise history. It beat on earnings in each of the trailing four quarters, the average surprise being 13.24%.In the last reported quarter, the company’s adjusted earnings per share (EPS) of 90 cents surpassed the Zacks Consensus Estimate by 2.27%.Q1 EstimatesThe Zacks Consensus Estimate for revenues is pegged at $335.9 million, suggesting an increase of ...